Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Niagen Bioscience (NAGE) Assets: 2011-2025

Historic Assets for Niagen Bioscience (NAGE) over the last 12 years, with Sep 2025 value amounting to $98.1 million.

  • Niagen Bioscience's Assets rose 73.63% to $98.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $98.1 million, marking a year-over-year increase of 73.63%. This contributed to the annual value of $68.3 million for FY2024, which is 24.22% up from last year.
  • Niagen Bioscience's Assets amounted to $98.1 million in Q3 2025, which was up 7.23% from $91.5 million recorded in Q2 2025.
  • Over the past 5 years, Niagen Bioscience's Assets peaked at $98.1 million during Q3 2025, and registered a low of $45.7 million during Q3 2022.
  • Moreover, its 3-year median value for Assets was $55.0 million (2023), whereas its average is $65.4 million.
  • As far as peak fluctuations go, Niagen Bioscience's Assets declined by 29.20% in 2022, and later spiked by 73.63% in 2025.
  • Niagen Bioscience's Assets (Quarterly) stood at $57.8 million in 2021, then decreased by 6.54% to $54.1 million in 2022, then climbed by 1.68% to $55.0 million in 2023, then grew by 24.22% to $68.3 million in 2024, then soared by 73.63% to $98.1 million in 2025.
  • Its last three reported values are $98.1 million in Q3 2025, $91.5 million for Q2 2025, and $81.3 million during Q1 2025.